Form 4: Recursion Pharmaceuticals COO Tina Marriott Executes Stock Option and Sells Shares Under 10b5-1 Plan

Tina Marriott, President and COO of Recursion Pharmaceuticals, exercised stock options and sold shares of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Summary

• On April 25, 2024, Tina Marriott, the President and COO of Recursion Pharmaceuticals, exercised stock options to acquire 3,000 shares of Class A Common Stock at a price of $1.06 per share.
• Simultaneously, Marriott sold 3,000 shares of Class A Common Stock at a weighted average price of $7.6735 per share, with individual trades ranging from $7.50 to $7.86.
• These transactions were executed under a pre-arranged 10b5-1 trading plan established on March 1, 2023.
• Following these transactions, Marriott directly owns 543,231 shares of Recursion Pharmaceuticals Class A Common Stock.
• Marriott also holds options to purchase a total of 1,625,049 shares of Class A Common Stock at various exercise prices and expiration dates.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment.

Positives

• The transactions were executed under a pre-arranged 10b5-1 trading plan, which can mitigate concerns about insider trading.

Risks

• Executive stock sales can sometimes be perceived negatively by investors, although the 10b5-1 plan mitigates this concern.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies. The use of a 10b5-1 trading plan is a standard practice to allow insiders to sell shares without raising concerns about insider trading.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
• The vesting schedules for the stock options are typical, with vesting occurring over several years.

Stakeholder Impact

• The stock sale could have a minor impact on shareholders, but the existence of the 10b5-1 plan suggests it was pre-planned and not based on inside information.

Key Dates